Liraglutide vs Semaglutide
Weekly vs daily GLP-1: the next-gen champion vs the proven original.
Weight LossGLP-1MetabolicUpdated March 2026
VS
Quick Verdict
Semaglutide delivers superior weight loss (15–20% vs 5–10%) with more convenient weekly dosing. Liraglutide has a longer safety track record and daily dosing allows finer control over side effects. Semaglutide is the clear winner for most people.
Best for
Liraglutide
Greater weight loss, weekly convenience, cardiovascular risk reduction. The standard of care for GLP-1 therapy.
Best for
Semaglutide
Daily dosing flexibility, those who want to titrate side effects more precisely, long safety history. A fallback if semaglutide is not tolerated.
Head-to-Head Comparison
Liraglutide
Semaglutide
Full Name
Full Name
Liraglutide (GLP-1 Receptor Agonist)
Semaglutide (GLP-1 Receptor Agonist)
Category
Category
GLP-1 Receptor Agonist (First-Gen)
GLP-1 Receptor Agonist
Mechanism
Mechanism
First-generation GLP-1 receptor agonist. Slows gastric emptying, reduces appetite, and increases insulin secretion via GLP-1 pathway activation.
Mimics GLP-1 hormone, slowing gastric emptying, increasing insulin secretion, and acting on brain appetite centers to reduce hunger and caloric intake.
Best For
Best For
- • Weight loss (FDA-approved as Saxenda)
- • Type 2 diabetes management (Victoza)
- • Those preferring daily vs weekly injection
- • Appetite suppression
- • Weight loss (15–20% body weight)
- • Appetite suppression
- • Blood sugar regulation
- • Cardiovascular risk reduction
Evidence Level
Evidence Level
Strong— FDA-approved (Saxenda/Victoza), extensive Phase 3 trial data
Strong— FDA-approved, extensive Phase 3 trials (STEP, SELECT)
Typical Dosing
Typical Dosing
0.6–3mg daily (titrated)
Subcutaneous injection, once daily
Subcutaneous injection, once daily
0.25mg–2.4mg weekly (titrated)
Subcutaneous injection, once weekly
Subcutaneous injection, once weekly
Administration
Administration
Subcutaneous injection, once daily
Subcutaneous injection, once weekly
Time to Effect
Time to Effect
2–4 weeks for appetite; 8–12 weeks for significant weight loss
2–4 weeks for appetite; 12–16 weeks for significant weight loss
Side Effects
Side Effects
Nausea, vomiting, diarrhea. Similar to semaglutide but generally less effective for weight loss.
Nausea, vomiting, diarrhea (usually transient). Rare: pancreatitis.
Blood Test
Blood Test
Required (A1c, metabolic panel)
Recommended (A1c, metabolic panel)
Price Tier
Price Tier
$$$
$$$$
ProtocolRx
ProtocolRx
Not offered
✓ We offer this
Which One Should You Choose?
Choose Liraglutide if you...
- ✓Want an FDA-approved GLP-1 for weight loss
- ✓Prefer daily dosing for more control over side effects
- ✓Have type 2 diabetes
- ✓Want a well-established GLP-1 with long safety record
- ✓Cannot access or tolerate semaglutide
Choose Semaglutide if you...
- ✓Want significant weight loss (15%+ body weight)
- ✓Struggle with appetite and portion control
- ✓Have type 2 diabetes or insulin resistance
- ✓Want cardiovascular risk reduction
- ✓Are okay with weekly injections
Not sure which is right for you?
Take our quiz and we'll recommend the right compounds for your specific goals and health profile.
Build Your Protocol →